Study Details

Back
Study ID 1585-CL-0006
Study Title Phase II dose range-finding study of ASP1585 in chronic kidney disease patients on hemodialysis with hyperphosphatemia(Original language of CSR synopsis is Japanese.)
Clinicaltrials.gov Identifier NCT02753894
Compound Name ASP1585 / bixalomer
Medical Indication or Disease Hyperphosphatemia
Study Sponsor Astellas Pharma Inc.
Collaborator Not Applicable
Study Start Date 22-Jan-2008
Study Completion Date 17-Jun-2008
Clinical Study Result
Select the language
Japanese
Plain Language Summary
Select the language
Not Available

QUICK SEARCH

USEFUL LINKS